BenzingaOctober 16, 2026 at 7:55 AM NY11 Days Ago
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
